Skip to main content
. Author manuscript; available in PMC: 2016 Dec 21.
Published in final edited form as: Nanoscale. 2015 Nov 17;7(47):20211–20219. doi: 10.1039/c5nr05869d

Figure 5.

Figure 5

In vivo efficacy of NP KU55933 as a radiosensitizer for non-small cell lung cancer. Mice bearing flank tumor xenografts (A) H460 and (B) A549 were intravenous injected with NP KU55933, KU55933 and saline followed by radiation therapy (XRT). Tumors were irradiated in 3 daily fractions of 5 Gy followed by chemotherapy injection.